Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VYVANSE
- Vyvanse in Children Aged 6 to 12 Years
- Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)
- Real World Evidence of the Efficacy and Safety of FOQUEST
- Stimulant Effects on Disruptive Behavior
- Lisdexamfetamine for Adults With Bulimia Nervosa
- Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
- IMProving Executive Function Study
- The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
- Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children
- Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)
- Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects
- Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT
- Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder
- An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
- Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder
- Omega-3 Supplementation to ADHD Medication in Children
- Lisdexamfetamine's Effect In ADHD in the Brain and Cognition
- Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
- LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy
- E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy
- LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women
- Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation
- Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity
- Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation
- Open Label Extension in Adults With Binge Eating Disorder (BED)
- Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
- Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
- Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
- Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
- SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
- Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD
- Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits
- Effects of LDX on Functioning of College Students With ADHD
- Attention & Memory Impairments in Menopausal Women
- To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder
- Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
- Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
- Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate
- Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss
- Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
- Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)
- Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression
- Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity
- Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits
- SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
- Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms
- A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers
- Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)
- Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder
- Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)
- Effect of Vyvanse on Driving in Young Adults With ADHD
- Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution
- Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study
- Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults
- Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
- Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study
- Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
- The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading
- Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse
- A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)
- Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD
Clinical trials list
click for details